These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8267649)

  • 1. Combination studies with 3'-azido-3'-deoxythymidine (AZT) plus ICI D1694. Cytotoxic and biochemical effects.
    Pressacco J; Erlichman C
    Biochem Pharmacol; 1993 Dec; 46(11):1989-97. PubMed ID: 8267649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICI D1694 and idoxuridine: a synergistic antitumor combination.
    Pressacco J; Hedley DW; Erlichman C
    Cancer Res; 1994 Jul; 54(14):3772-8. PubMed ID: 8033097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic and biochemical implications of combining AZT and AG-331.
    Pressacco J; Mitrovski B; Erlichman C
    Cancer Chemother Pharmacol; 1995; 35(5):387-90. PubMed ID: 7850919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical modulation of iododeoxyuridine by N6-[4-(morpholinosulfonyl)benzyl]-N6-methyl-2,6-diaminobenz[cd]indole glucuronate (AG-331) leading to enhanced cytotoxicity.
    Pressacco J; Mitrovski B; Hedley DW; Tsang R; Erlichman C
    Biochem Pharmacol; 1995 Jun; 50(1):55-60. PubMed ID: 7605345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time dependence of DNA lesions and growth inhibition by ICI D1694, a new quinazoline antifolate thymidylate synthase inhibitor.
    Yin MB; Guimaraes MA; Zhang ZG; Arredondo MA; Rustum YM
    Cancer Res; 1992 Nov; 52(21):5900-5. PubMed ID: 1394217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular heterogeneity in DNA damage and growth inhibition induced by ICI D1694, thymidylate synthase inhibitor, using single cell assays.
    Schöber C; Gibbs JF; Yin MB; Slocum HK; Rustum YM
    Biochem Pharmacol; 1994 Aug; 48(5):997-1002. PubMed ID: 8093112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.
    Jackman AL; Taylor GA; Gibson W; Kimbell R; Brown M; Calvert AH; Judson IR; Hughes LR
    Cancer Res; 1991 Oct; 51(20):5579-86. PubMed ID: 1913676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thymidylate synthase inhibition on thymidine kinase activity and nucleoside transporter expression.
    Pressacco J; Mitrovski B; Erlichman C; Hedley DW
    Cancer Res; 1995 Apr; 55(7):1505-8. PubMed ID: 7882359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8.
    Darnowski JW; Goulette FA
    Biochem Pharmacol; 1994 Nov; 48(9):1797-805. PubMed ID: 7980649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The measurement of polyglutamate metabolites of the thymidylate synthase inhibitor, ICI D1694, in mouse and human cultured cells.
    Gibson W; Bisset GM; Marsham PR; Kelland LR; Judson IR; Jackman AL
    Biochem Pharmacol; 1993 Feb; 45(4):863-9. PubMed ID: 7680860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
    Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
    Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical effects of folate-based inhibitors of thymidylate synthase in MGH-U1 cells.
    Mitrovski B; Pressacco J; Mandelbaum S; Erlichman C
    Cancer Chemother Pharmacol; 1994; 35(2):109-14. PubMed ID: 7987985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thymidylate synthase inhibitor, ICI D1694, overcomes translational detainment of the enzyme.
    Keyomarsi K; Samet J; Molnar G; Pardee AB
    J Biol Chem; 1993 Jul; 268(20):15142-9. PubMed ID: 8325888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Plasmodium falciparum to a combination of thymidine and ICI D1694, a quinazoline antifolate directed at thymidylate synthase.
    Rathod PK; Reshmi S
    Antimicrob Agents Chemother; 1994 Mar; 38(3):476-80. PubMed ID: 8203840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the reduced-folate carrier and metabolism to intracellular polyglutamates for the activity of ICI D1694.
    Jackman AL; Gibson W; Brown M; Kimbell R; Boyle FT
    Adv Exp Med Biol; 1993; 339():265-76. PubMed ID: 7513935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative cytotoxicity of folate-based inhibitors of thymidylate synthase and 5-fluorouracil +/- leucovorin in MGH-U1 cells.
    Erlichman C; Mitrovski B
    Cancer Chemother Pharmacol; 1994; 34(1):51-6. PubMed ID: 8174202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo.
    Tosi P; Calabresi P; Goulette FA; Renaud CA; Darnowski JW
    Cancer Res; 1992 Aug; 52(15):4069-73. PubMed ID: 1638518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of target enzyme associated with the action of antifolates.
    Rustum YM; Cao S; Yin MB
    Adv Enzyme Regul; 1994; 34():57-70. PubMed ID: 7942285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic characteristics of ICI D1694: a quinazoline antifolate which inhibits thymidylate synthase.
    Ward WH; Kimbell R; Jackman AL
    Biochem Pharmacol; 1992 May; 43(9):2029-31. PubMed ID: 1596289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyurea enhances 3'-azido-3'-deoxythymidine (AZT) cytotoxicity in human chronic myeloid leukemia models.
    Tosi P; Visani G; Ottaviani E; Tura S; Darnowski JW
    Eur J Haematol; 1994 May; 52(5):291-5. PubMed ID: 8020629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.